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Multinational corporations have made vast sums marketing these products globally by relying on international intellectual property laws that provide patent protection throughout the world. In recent years, such patent protection has been significantly broadened and strengthened as a result of the entry into force of the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement) negotiated under the auspices of the World Trade Organisation.
---under international law and may be freely exploited without compensation or control by the international community. This chapter examines the international laws and policies governing the exploitation of genetic resources in areas beyond national jurisdiction. It contends that current methods of determining how benefits from commercial exploitation of these genetic resources are distributed globally should be modified as a result of increased protection of intellectual property rights provided to the biotechnology industry under the TRIPS Agreement regime. Existing international legal provisions that require revenue sharing for the exploitation of minerals on the extended continental shelf beyond 200 nautical miles might serve as a useful model in developing a legal framework governing the commercialisation of genetic resources beyond national jurisdiction.
DEEP-SEABED MARINE GENETIC RESOURCES AND THEIR USES
It has been estimated that between 500,000 and 100 million species live in the deep-sea portions of the world's oceans.
5
The vast majority of these species remain undiscovered and are yet to be described. 6 For example, as much as ten per cent of the total living biomass on earth exists as oceanic subsurface bacteria, most of it unidentified.
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The microbial and prokaryote gene richness found in the oceans is expected to be orders of magnitude greater than the rest of the biosphere.
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Because areas beyond national jurisdiction make up over 60 per cent of the world's oceans, they represent a huge reservoir of naturally-occurring genetic information.
There is growing scientific and commercial interest in marine organisms and the genetic information that they contain. As of 2007, more than 15,000 molecules from marine genetic resources (MGRs) had been isolated and described. 9 The unique structures and potent bioactivities found in marinederived molecules are being investigated for a variety of commercial uses. These include: 1) pharmaceutical compounds and molecular probes; 2) en-
